RHOFADE Trademark

Trademark Overview

On Wednesday, June 11, 2014, a trademark application was filed for RHOFADE with the United States Patent and Trademark Office. The USPTO has given the RHOFADE trademark a serial number of 86306966. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, July 30, 2024. This trademark is owned by Allergan, Inc.. The RHOFADE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment of erythema associated with rosacea
rhofade

General Information

Serial Number86306966
Word MarkRHOFADE
Filing DateWednesday, June 11, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, July 30, 2024
Registration Number5232934
Registration DateTuesday, June 27, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment of erythema associated with rosacea
Translation of Words in MarkThe word(s) "RHOFADE" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 21, 2014
Primary Code005
First Use Anywhere DateFriday, April 21, 2017
First Use In Commerce DateFriday, April 21, 2017

Trademark Owner History

Party NameMAYNE PHARMA LLC
Party Type33 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressRALEIGH, NC 27609
Party NameEPI HEALTH, LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWayne, PA 19087
Party NameACLARIS THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWAYNE, PA 19087
Party NameAllergan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Saturday, September 20, 2014NON-FINAL ACTION WRITTEN
Saturday, June 14, 2014NEW APPLICATION ENTERED
Saturday, June 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 20, 2014ASSIGNED TO EXAMINER
Saturday, September 20, 2014NON-FINAL ACTION E-MAILED
Saturday, September 20, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 11, 2014PUBLISHED FOR OPPOSITION
Monday, September 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 23, 2014ASSIGNED TO LIE
Tuesday, September 30, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 30, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 1, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 7, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 22, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 26, 2015SOU EXTENSION 2 GRANTED
Tuesday, November 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 6, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 23, 2015SOU TEAS EXTENSION RECEIVED
Monday, March 23, 2015SOU EXTENSION 1 FILED
Monday, March 23, 2015SOU EXTENSION 1 GRANTED
Wednesday, March 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 15, 2015SOU TEAS EXTENSION RECEIVED
Thursday, October 15, 2015SOU EXTENSION 2 FILED
Monday, October 26, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 25, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, October 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 12, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, April 12, 2016SOU EXTENSION 3 FILED
Monday, April 18, 2016SOU EXTENSION 3 GRANTED
Tuesday, April 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 31, 2016SOU TEAS EXTENSION RECEIVED
Monday, October 31, 2016SOU EXTENSION 4 FILED
Saturday, November 5, 2016SOU EXTENSION 4 GRANTED
Tuesday, November 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 25, 2017USE AMENDMENT FILED
Monday, May 8, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, May 19, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, May 20, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 27, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, December 19, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, January 16, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 16, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 4, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 1, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 22, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, November 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 27, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, November 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 3, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 30, 2024POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Tuesday, July 30, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 30, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, July 10, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, December 27, 2023TEAS SECTION 8 & 15 RECEIVED
Wednesday, July 10, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Related Keywords

rhofade associated rosacea erythema treatment preparation pharmaceutical